Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are
resistant to microbial growth. Also disclosed are formulations of gammahydroxybutyrate that …

The present invention provides a solid immediate release dosage form adapted for oral
administration of GHB. The solid immediate release dosage form includes an immediate …

US5990162A - Method for treatment of fibromyalgia and chronic fatigue syndrome - Google
Patents US5990162A - Method for treatment of fibromyalgia and chronic fatigue syndrome …

This patent application is a continuation of US applica tion Ser. No. 12/913,644, filed on Oct.
27, 2010, which is a continuation of US application Ser. No. 1 1/777,877 filed on Jul. 13 …

Provided herein are pharmaceutical compositions and formu lations comprising mixed salts
of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the …

US5840331A - Use of γ-hydroxybutyrate for the stimulation of sleep-related secretion growth
hormone and prolactin - Google Patents US5840331A - Use of γ-hydroxybutyrate for the …

Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are
resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that …

Controlled release dosage forms are described herein. The controlled release formulations
described herein provide prolonged delivery of high dose drugs that are highly water …

Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are
resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that …

Controlled release dosage forms are described herein. The controlled release formulations
described herein provide prolonged delivery of high dose drugs that are highly water …